Universal Radical Cure | APMEN TechTalks

Malaria elimination in the Asia Pacific is hindered by recurring Plasmodium vivax infections, often following acute P. falciparum cases. This webinar discusses a randomized trial on using primaquine for both species, highlighting its potential to prevent vivax relapses. This unified treatment approach could ease healthcare strain and improve resource efficiency in co-endemic regions, supporting elimination goals.

Moderator:

• Dr. Neena Valecha, Chair of APMEN Vivax Working Group

Speakers:

• Dr. Kamala Thriemer, Principal Research Fellow, Menzies School of Health Research, Australia
• Dr. Hammad Habib, Advisor Malaria, Global Management Unit at Ministry of National Health, Regulation and Coordination, Pakistan 
• Dr. Peter Olumese, Medical Officer, Malaria Case Management at Global Malaria Programme, WHO Geneva